SBIRI: A Complete Guide to the Small Business Innovation Research Initiative

There is a specific, well known moment in a biotech startup's life when proof of concept simply is not enough anymore. The science works in a controlled setting, but turning that early validation into an actual product, ready for real world testing and eventual market entry, demands a different kind of investment: sustained, patient, and substantial enough to carry a company through months or years of product development.

The Small Business Innovation Research Initiative (SBIRI), launched in 2005 by the Department of Biotechnology under the Ministry of Science and Technology to boost public private partnership in the sector, is the Biotechnology Industry Research Assistance Council's answer to that exact stage. Where the BIG scheme funds the earliest idea to prototype leap, SBIRI picks up from there, supporting registered companies that have already moved beyond proof of concept and need serious capital to carry a validated technology through product development and toward market readiness. It is a structured, phased programme, deliberately designed to scale funding alongside a startup's growing technical and commercial maturity.

The Funding Opportunity: What SBIRI Actually Offers

SBIRI funding is structured in phases that track a startup's development stage.

• Phase I, support up to Rs. 50 lakh, aimed at concept validation, typically over a period of around 12 months.
• Phase II, support up to Rs. 1 crore, aimed at product development and scale up, typically extended over around 24 months.
• Combined R&D and product development: where research and development and product development are proposed simultaneously, SBIRI can extend a maximum grant of Rs. 50 lakh alongside a soft loan of up to Rs. 10 crore, reflecting the scheme's flexibility in structuring larger, more complex support packages.
• Cost sharing by project size: for projects costing up to Rs. 25 lakh, the grant can cover up to 80 percent of the project cost. For projects between Rs. 25 lakh and Rs. 100 lakh, the grant covers up to 50 percent of project cost, with a minimum grant of Rs. 20 lakh. Beyond Rs. 100 lakh in project cost, applicants become eligible for an interest free loan on top of the government grant, up to 50 percent of the amount by which the project exceeds Rs. 100 lakh, subject to a loan limit of Rs. 50 lakh.
• Selection process: applications typically go through a structured, three stage evaluation: an online application screening, a presentation before a national expert committee, and final approval by the BIRAC board.

Who is eligible

• Unlike BIG, SBIRI is available only to registered companies. Individual innovators without a formal entity are not eligible, making it a natural next step for startups that have already used BIG or a similar mechanism to validate their initial idea.
• Applicants should have moved beyond pure proof of concept work, ideally with a working prototype and preliminary supporting data.
• Projects should represent genuine technology driven or IP driven innovation in the biotechnology space, spanning healthcare, agriculture, industrial biotechnology, and related sectors.
• Patent filings and peer reviewed publications tied to the underlying innovation, while not always mandatory, meaningfully strengthen most successful applications.

How the process works

1. Applications typically open twice a year, commonly in January and July, aligned with BIRAC's broader call calendar.
2. Submit your proposal through BIRAC's online application system, providing evidence of your prior proof of concept work and a clear product development plan.
3. Shortlisted applications proceed to a presentation before a national expert committee, who evaluate the technical and commercial merit of the proposal.
4. Final approval rests with the BIRAC board, after which funding is disbursed according to the applicable phase structure, Phase I, Phase II, or a combined grant and loan arrangement.

Because SBIRI's phase structure and specific funding caps are periodically revised, it is worth confirming the current call's exact terms directly through BIRAC's official channels before applying.

Where SBIRI Fits in the Broader BIRAC Ecosystem

SBIRI is frequently positioned as the natural next step for startups that have already exhausted early stage support like the BIG grant and are ready for the more substantial, product development focused funding SBIRI provides. It is also commonly discussed alongside the Biotechnology Industry Partnership Programme (BIPP). Both address more advanced, product stage biotech development, though BIPP tends to be open to companies of all sizes and covers even larger scale, higher relevance projects, while SBIRI's phased, company specific structure makes it especially well suited to growing startups scaling up from an already validated prototype.